NLRC3 and dementia: Considering that wild type NLRC3 is involved in lowering inflammation, and overexpression has been shown to inhibit the deposition of A-beta, and reverse the degeneration of neurons in APP/PS1 mice [42], we speculate that rare variants in NLRC3 elevate inflammation, resulting in increased neurodegeneration and dementia symptoms.